Microfluidic Wedge Chamber for Field Mastitis Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for diagnosing subclinical mastitis in cows, such as the Somatic Cell Count (SCC), are impractical for field use due to high costs and variability, and existing wedge chamber designs for leukocyte differential assays are cumbersome and prone to leaks or improper liquid placement.

Innovation Solution

A novel microfluidic wedge chamber assembly with an adhesive-backed film securing the wedge top to the base, forming a stable wedge-shaped chamber for easy liquid addition and minimizing movement, allowing for accurate and quick leukocyte differential assays using small milk volumes.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional SCC methods are used for diagnosing subclinical mastitis, then diagnostic accuracy is maintained, but field usability deteriorates due to high costs and variability

Engineering Contradiction:
Improvediagnostic accuracyVSAvoidfield usability
Core Design Contradiction:
Measurement precisionVSEase of operation

Solution Approach 1:

The patent employs a disposable microfluidic chamber assembly that can be discarded after a single use. This eliminates the need for expensive, complex laboratory equipment while maintaining diagnostic accuracy. The disposable nature ensures consistency across different field users without requiring extensive training or calibration, directly addressing the contradiction between maintaining measurement precision and improving ease of operation in field settings.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

2Adaptability or versatility

If existing wedge chamber designs are used for leukocyte differential assays, then assay capability is provided, but reliability deteriorates due to leaks and improper liquid placement

Engineering Contradiction:
Improveassay capabilityVSAvoidleak prevention
Core Design Contradiction:
Adaptability or versatilityVSReliability

Solution Approach 1:

The patent utilizes a thin film adhesive layer to seal the wedge-shaped chamber, creating a flexible yet reliable barrier that prevents leaks. This thin film approach maintains the wedge chamber's assay capability while significantly improving reliability by eliminating the leakage and improper liquid placement issues associated with rigid, traditional chamber designs. The flexible seal adapts to the chamber geometry, ensuring consistent performance.

Inventive Principle:
Principle #30Flexible shells and thin films

3Measurement precision

If manual leukocyte differential methods are used, then diagnostic accuracy is maintained, but productivity deteriorates due to time consumption and training requirements

Engineering Contradiction:
Improvediagnostic accuracyVSAvoidtesting speed
Core Design Contradiction:
Measurement precisionVSProductivity

Solution Approach 1:

The microfluidic chamber assembly is designed to guide liquid addition and distribution automatically through its wedge geometry and capillary action, eliminating the need for manual manipulation and extensive technician training. The chamber self-regulates liquid flow and positioning, maintaining diagnostic accuracy while dramatically improving productivity by enabling rapid testing without requiring highly trained personnel or time-consuming manual procedures.

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The microfluidic wedge chamber enables rapid, accurate, and quantitative leukocyte differential analysis, making it suitable for field use by farmers, with results comparable to manual methods and reducing the need for extensive training or expensive equipment.

Implementation Method 1

an adhesive-backed film securing the wedge top to the base

Methodology Applied
Scientific EffectAdhesion: Adhesive

Data Source

PatentEP2005155B1Mastitis assay employing a microfluidic chamber assembly
Publication Date: 2021.06.30 ADVANCED ANIMAL DIAGNOSTICS
  • EP2005155B1 patent drawingFigure 1
  • EP2005155B1 patent drawingFigure 2
  • EP2005155B1 patent drawingFigure 3

AI summary

The present invention relates to a device and method for the detection of mastitis or other disease from a body fluid of a mammal for example from cow's milk. The device and method relates to a wedge microfluidic chamber for using a minimal amount of fluid and being able to use the device to observe leukocytes in a mono-layer for the purpose of disease detection, cell counts or the like.